Winning back talent is becoming the fight of our lives.
Plus, Why We Should Still Be Thinking About Cumulative Population Immunity
Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.
An Analysis of Infection Odds Based on US County
Our new model projects the chance that within a gathering of random people, there's an active COVID-19 infection.
Researchers Explore Organ Recovery and Transplantation Opportunities
Although nearly half of US adults are registered organ donors, transplant waitlists remain long. New research outlines how to accelerate improvement and offers key considerations for payers and regulators.
Drive Innovation
March 16, 2021
The COVID-19 Long Haul, One Year Later
Timeline to Normalcy - Updated March 15, 2021
Our revised analysis and state-by-state outlook suggest the US may achieve pHIT in early summer if vaccinations align with a more optimistic scenario.
Timeline to Normalcy - Updated January 25, 2021
The journey to normalcy involves understanding and addressing many different factors. Our latest analysis suggests we are likely to achieve pHIT in the US on average in late summer.
New Predictions on COVID-19 Vaccines and Herd Immunity
How COVID-19 case counts and vaccines may get us back to normalcy by June.
The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.
Engage Consumers
September 10, 2020
Empathy at Scale: A COVID-19 Antidote?
COVID-19 is an opportunity to take empathy a step further and build consumer rapport during difficult times.
Health systems have seen a breakthrough in agility. Analyzing earlier experiences will drive its sustainability.
